Coulier explained that he had caught a cold while his immune system was weakened, after his last session of chemotherapy. His condition worsened, leading to hospitalization.
The drug, trametinib, targets a downstream component of the RAS signaling pathway, which regulates cell growth and has implications for several cancers in humans and animals.